A compound's AI origin story is not by itself a reason to expect it to do better in the clinic.

Added to korrents 7 Sept 2026 · How quotes work · Something wrong? Tell us

Shared subject first, then similar wording. They may agree or disagree.

• There are few clear-cut cases in biopharma today where buying an AI system is obviously worth it. DLDerek Lowe14 Oct 2024
• The hypotheses AI 'co-scientist' systems are producing are ones the literature already contains, and the publicity around them does not say so. DLDerek Lowe27 May 2026
• We have neither the data nor the insight to use machine learning to pick drug targets that succeed in the clinic more often. DLDerek Lowe25 May 2023
• A paper reporting an AI-generated molecule must publish the model's entire training set in detail, or the result cannot be judged. DLDerek Lowe4 Feb 2020
• Semiconductor infrastructure has not kept up with AI's growth, and closing that gap needs capacity built in unconventional ways. LTLip-Bu Tan18 Jun 2026

See this claim on the map